Trailing Dividend / Share
$6.22
AbbVie Inc. (ABBV) Dividend History
Income profile from 2013 to 2026 with payout safety and yield-on-cost trend
Dividend Yield
2.7%
Payout Ratio
2.6%
Sustainable
Dividend Streak
12 years
3-Second Income Check
Safety
2.6% payout ratio with sustainable safety profile.
Consistency
12 straight years of dividend increases.
Income Trend
Yield on cost is 6.2% and trend is rising.
Dividend Scorecard
Yield & Income
Dividend Yield2.7%
Trailing DPS$6.22
FrequencySemi-Annual
Payments / 12M5
Payout Safety
Earnings Payout2.6%
Earnings SafetySustainable
FCF Payout53.6%
FCF SafetyAdequate
Piotroski F-Score6/9
Growth
Growth Streak12 years
3Y CAGR5.2%
5Y CAGR6.8%
Yield on Cost (5Y)6.2%
YOC Trendrising
Total Returns
Buyback Yield0.4%
Total Shareholder Yield3.1%
1Y Total Return14.2%
5Y Total Return141.7%
Div Contribution (5Y)27.6%
Estimated $10K growth (return + dividends):
5Y ago$24,16610Y ago$51,29820Y ago$81,712
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
Income Growth Story
Dividend per share and yield on cost over time (14 years of payments)
Dividend Safety Story
EPS is the container — dividend is what's drawn out
Dividend Analysis
Payout Safety
AbbVie Inc. distributes 2.6% of earnings as dividends (Sustainable). When measured against free cash flow—a stricter test—the payout ratio stands at 53.6%, rated "Adequate".
Piotroski F-Score: 6/9 — moderate financial health.
Growth Track Record
ABBV has raised its dividend for 12 consecutive years, with a 3-year CAGR of 5.2% and 5-year CAGR of 6.8%.
Total Shareholder Returns
Beyond cash dividends, ABBV returns capital through share repurchases. The combined picture: 2.7% dividend yield, 0.4% buyback yield, 3.1% total shareholder yield.
Income Trend & Total Return
Yield on cost (5-year basis) has reached 6.2% and is currently rising. The 5-year total return is 141.7%, with dividends contributing 27.6% of that performance.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $51,298 today.
Recent Dividend Payments
Last 20 payments · Semi-Annual
TTM Total$30.38
Avg/Payment$1.5190
| Ex-Date | Amount | Change | Yield % | Payment Date |
|---|---|---|---|---|
| Apr 15, 2026Latest | $1.7300 | — | 2.90% | May 15, 2026 |
| Jan 16, 2026 | $1.7300 | ↑ +5.5% | 3.10% | Feb 17, 2026 |
| Oct 15, 2025 | $1.6400 | — | 2.90% | Nov 14, 2025 |
| Jul 15, 2025 | $1.6400 | — | 3.47% | Aug 15, 2025 |
| Apr 15, 2025 | $1.6400 | — | 3.61% | May 15, 2025 |
| Jan 15, 2025 | $1.6400 | ↑ +5.8% | 3.67% | Feb 14, 2025 |
| Oct 15, 2024 | $1.5500 | — | 3.23% | Nov 15, 2024 |
| Jul 15, 2024 | $1.5500 | — | 3.65% | Aug 15, 2024 |
Dividend Peer Comparison
Peer group: Specialty and biologics-focused pharma
#2 yield in peer group
Div Yield
2.7%
#2 of 3
Safety
Sustainable
2.6% payout
Streak
12Y
6.8% 5Y CAGR
Total Shareholder
3.1%
#2 of 3
Annual Dividend History
17 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2026YTD | $3.46 | — | 2 | — | — | — | 3.3% |
| 2025 | $6.56 | 5.8% | 4 | — | — | — | 6.2% |
| 2024 | $6.20 | 4.7% | 4 | $2.39 | 259.4% | 0.39x | 5.9% |
| 2023 | $5.92 | 5.0% | 4 | $2.72 | 217.6% | 0.46x | 5.6% |
| 2022 | $5.64 | 8.5% | 4 | $6.63 | 85.1% | 1.18x | 5.4% |
| 2021 | $5.20 | 10.2% | 4 | $6.45 | 80.6% | 1.24x | 4.9% |
| 2020 | $4.72 | 10.3% | 4 | $2.72 | 173.5% | 0.58x | 4.5% |
| 2019 | $4.28 | 19.2% | 4 | $5.28 | 81.1% | 1.23x | 4.1% |
| 2018 | $3.59 | 40.2% | 4 | $3.68 | 97.6% | 1.03x | 3.4% |
| 2017 | $2.56 | 12.3% | 4 | $3.30 | 77.6% | 1.29x | 2.4% |
See ABBV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABBV Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ABBV vs AGIO
See how ABBV stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How much dividend does ABBV pay per share?
AbbVie Inc. (ABBV) pays a trailing 12-month dividend of $6.22 per share, with a current dividend yield of +2.7%. Payments are made Semi-Annual.
When is ABBV's next ex-dividend date?
ABBV's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. ABBV typically pays dividends Semi-Annual.
Is ABBV's dividend safe?
ABBV's dividend safety is rated "Sustainable" based on an earnings payout ratio of +2.6% and FCF payout ratio of +53.6%. With 12 consecutive years of dividend growth, the track record supports sustainability.
Is ABBV a Dividend Achiever?
Yes, AbbVie Inc. is classified as a Dividend Achiever with 12 consecutive years of dividend increases. The 5-year dividend CAGR is +6.8%, demonstrating above-inflation dividend growth.
How often does ABBV pay dividends?
AbbVie Inc. pays dividends Semi-Annual. The trailing 12-month total is $6.22 per share. Dividend data on this page covers 13+ years from 2013 to 2026.
How much would $10,000 invested in ABBV grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in ABBV five years ago would be worth approximately $24,166 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is ABBV's yield on cost for long-term holders?
ABBV's yield on cost — the current dividend divided by the original purchase price — is +6.2% for a 5-year holding period. This means long-term holders earn a higher effective yield than today's +2.7% market yield, thanks to consistent dividend growth.